SCHEMBL5593553

SCHEMBL5593553

Cc1nc(-c2cccc(-n3sc(Cl)cc3=O)c2)cs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 4/20 0.46
PRMT6 Q96LA8 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
GFER P55789 1/20 0.44
ALDH1A1 P00352 5/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 3/20 0.43
GAA P10253 3/20 0.43
USP2 O75604 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KAT2B Q92831 1/20 0.43
TRIM24 O15164 1/20 0.43
LMNA P02545 4/20 0.42
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.42
ESR2 Q92731 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5593596 0.81 RECQL (0.51) RECQLTSHRHTTPRMT6NPSR1
SCHEMBL5593589 0.79 KAT2B (0.42) KAT2B
SCHEMBL982911 0.73 RECQL (0.66) RECQLTSHRHTTPRMT6GFER
SCHEMBL19627025 0.72 TSHR (0.60) RECQLTSHRHTTPRMT6NPSR1
SCHEMBL5593605 0.72 RAB9A (0.46) RECQLTSHRHTTPRMT6NPSR1
SCHEMBL19626731 0.71 NPSR1 (0.60) RECQLTSHRHTTPRMT6NPSR1
SCHEMBL8257849 0.70 RECQL (0.70) RECQLTSHRHTTPRMT6NPSR1
SCHEMBL19195984 0.70 RECQL (0.60) RECQLTSHRHTTPRMT6GFER
SCHEMBL11193393 0.70 KAT2B (0.60) NPSR1ALDH1A1MAPTHPGDKAT2B
SCHEMBL8257041 0.69 HTR7 (0.56) RECQLTSHRHTTPRMT6NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
US-20060293374-A1 Substituted isothiazolones JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293374-A1 Substituted isothiazolones LTB4R2, PTGES2, CYSLTR2 RECQL 2384/4885TSHR 2780/4885HTT 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.